The age-related macular degeneration market has achieved a valuation of US$ 11 Billion by the year 2022. Moreover, during the period of assessment from 2022 to 2032, substantial growth is anticipated with a remarkable compound annual growth rate (CAGR) of 6.2%, resulting in a market value of US$ 20 Billion. Age-Related Macular Degeneration (AMD) is a progressive eye condition affecting […]